ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q3 2021. The put-call ratio across all filers is 0.36 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,024,671 | -4.8% | 74,601 | +7.8% | 1.12% | -3.1% |
| Q2 2023 | $2,126,931 | -13.9% | 69,191 | +0.9% | 1.16% | -9.5% |
| Q1 2023 | $2,471,586 | +14.4% | 68,598 | +25.5% | 1.28% | +8.9% |
| Q4 2022 | $2,160,993 | +6.6% | 54,681 | +8.3% | 1.17% | -4.2% |
| Q3 2022 | $2,028,000 | -63.9% | 50,473 | -62.2% | 1.23% | -61.5% |
| Q2 2022 | $5,613,000 | +9.9% | 133,509 | +1.8% | 3.18% | +28.9% |
| Q1 2022 | $5,109,000 | +1.0% | 131,143 | +3.4% | 2.47% | +14.9% |
| Q4 2021 | $5,056,000 | +31.6% | 126,883 | +19.3% | 2.15% | +25.6% |
| Q3 2021 | $3,842,000 | – | 106,321 | – | 1.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |